Driehaus Capital Management LLC Rhythm Pharmaceuticals, Inc. Transaction History
Driehaus Capital Management LLC
- $10.3 Billion
- Q4 2024
A detailed history of Driehaus Capital Management LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 1,290,975 shares of RYTM stock, worth $68.4 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
1,290,975
Previous 1,299,490
0.66%
Holding current value
$68.4 Million
Previous $68.1 Million
6.0%
% of portfolio
0.7%
Previous 0.67%
Shares
7 transactions
Others Institutions Holding RYTM
# of Institutions
215Shares Held
64.4MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$357 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$348 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$322 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$322 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$195 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.95B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...